Pune, India, June 29, 2022 (GLOBE NEWSWIRE) -- The global hormone replacement therapy market size was USD 13.40 billion in 2020. The market is projected to grow from USD 14.17 billion in 2021 to USD 21.49 billion in 2028 at a CAGR of 6.1% in the 2021-2028 period. This information is provided by Fortune Business Insights, in its report titled, Hormone Replacement Therapy Market, 2021-2028.”
According to our expert analysts, the market is witnessing growth, owing to its development in several other hormone-associated illnesses concerned with diverse age groups that are impacting both, women as well as men.
Industry Developments:
May 2021: Myovant Sciences GmbH declared that it gained sanction from the U.S. FDA for hormone therapy Myfembree as a treatment for uterine fibroid bleeding. The drug unveiled by Myovant is set to give uninterrupted competition to Abbvie with an extra dosing benefit.
Request a Sample Copy of the Research Report
Report Scope & Segmentation
| Report Coverage | Details |
| Forecast Period | 2021 to 2028 |
| Forecast Period 2021 to 2028 CAGR | 6.1% |
| 2028 Value Projection | USD 21.49 Billion |
| Base Year | 2020 |
| Market Size in 2021 | USD 14.17 Billion |
| Historical Data for | 2017 to 2019 |
| No. of Pages | 138 |
| Key Market Players | Novo Nordisk A/S (Bagsværd, Denmark), Pfizer Inc. (New York, U.S.), AbbVie’s (Lake Bluff, U.S.), Merck KGaA (Dermstadt, Germany), Endo International plc (Dublin, Ireland), Allergan plc (Irvine U.S) |
| Growth Drivers | Unveiling of Radical Drug Delivery Systems with Spurred Efficiency to Drive Market Growth |
| Therapy Type, Indication, Route of Administration, Distribution Channel, and Region are studied for the Market | |
| Principal Companies to Grasp Effective Tactics and Expand their Market Presence |
Drivers and Restraints:
Unveiling of Radical Drug Delivery Systems with Spurred Efficiency to Drive Market Growth
Hormone replacement therapy is vital for patients with growth hormone scarcities, women experiencing menopausal conditions, elderly population having hypogonadism, and other patients. The treatment is obtainable in several forms, which involve skin and buccal patches, injectable, and tablets, and others.
Attributed to the increase in implementation of these products across the world, numerous manufacturers are emphasizing on the development of the progressive drug delivery systems such as vaginal estrogen drugs as well as transdermal estrogen patches. This is expected to bolster the hormone replacement therapy market growth.
To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit:
https://www.fortunebusinessinsights.com/hormone-replacement-therapy-hrt-market-102543
A hormone replacement therapy is a treatment to replace the natural hormone when the body does not produce enough hormone. The hormonal replacement therapy is generally used to treat the menopause symptoms and to protect long term health. During the menopause, the female hormone level goes up and down. This can cause various symptoms, such as night sweat and vaginal dryness.
Thus, hormone replacement therapy helps to balance the level hormone among the females. In addition to this, hormone replacement therapy also helps in the prevention of cardiovascular diseases and osteoporosis after menopause in females. In addition to this, the hormone replacement therapy also reduces the chance of various diseases, including diabetes and bowel cancer. In male hormone replacement therapy, testosterone hormone is given to the man. Testosterone hormone is responsible for the development of male sex organs and producing male characteristics such as muscularity and facial hairs.
Hormone replacement therapy is generally used to balance the level of progesterone and estrogen hormone in females. Currently, the combination of drugs is used for hormone replacement therapy. The hormone replacement therapy can be given to various forms, including oral, parenteral, and transdermal. Oral intake of hormone drug is one of the most common routes of administration in the hormone replacement therapy.
Hormone therapy, including estrogen therapy and combined estrogen/progesterone therapy, has been currently approved by the Food and Drug Administration (FDA) for the treatment of osteoporosis among the females. There are many companies present in the market who are offering a variety of medicines for the hormone replacement therapy for both male and females.
Quick Buy Hormone Replacement Therapy Market
https://www.fortunebusinessinsights.com/checkout-page/102543
Segmentation:
Therapy Type, Indication, Route of Administration, Distribution Channel, and Region are studied for the Market
- On the basis of therapy type, the market is segregated into estrogen and combination replacement therapy, growth hormone replacement therapy, thyroid hormone replacement therapy, and testosterone hormone replacement therapy. Estrogen and combinations hormone replacement therapy led the market growth, owing to augmentation in the consciousness linked with menopause symptoms across the world.
- Based on indication, the market is classified into menopause, hypothyroidism, male hypogonadism, and growth hormone deficiency.
- On the basis of route of administration, the hormone replacement market is categorized into oral, transdermal, and parenteral.
- In terms of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies & stores, and online pharmacies.
- Geographically, the global market is branched into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Market Segmentations:
| Segmentation | By Therapy Type
|
By Indication
| |
By Route of Administration
| |
By Distribution Channel
|
Report Coverage:
The report offers a holistic evaluation of the hormone replacement therapy market along with present trends and forthcoming expectations to launch approximate investment profits. Moreover, a detailed examination of any forthcoming opportunities, threats, competitions or driving aspects is also conversed in the report. Step by step, methodical regional review is offered in the report.
COVID-19 influences have been added to the report to aid investors and business owners to perceive an amplified knowledge of the existing threats. The key players in the market are distinguished, and their tactics to bolster the market growth are mentioned in the report.
Regional Insights:
The market in North America was worth USD 7.07 billion in 2020 and held the maximum hormone replacement therapy market share. Moreover, the market is anticipated to lead the global market, owing to an increase in the occurrence of menopause and growth hormone scarcity illnesses.
Europe is the second dominant region, owing to an escalation in the hormonal conditions in women experiencing menopausal symptoms, older people undergoing hypothyroidism, and increase in growth hormone ailments.
Asia Pacific is projected to appear as one of the biggest suppliers of the product coupled with the highest CAGR in future.
Get your Customized Research Report:
List of Key Players Mentioned in the Report:
- Novo Nordisk A/S (Bagsværd, Denmark)
- Pfizer Inc. (New York, U.S.)
- AbbVie’s (Lake Bluff, U.S.)
- Merck KGaA (Dermstadt, Germany)
- Endo International plc (Dublin, Ireland)
- Allergan plc (Irvine, U.S.)
- Eli Lilly and Company (Indianapolis, U.S.)
- Mithra Pharmaceuticals (Liege, Belgium)
- Amgen (Thousand Oaks, U.S.)
Table Of Content
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Market Trends
- Key Insights
- Pipeline Analysis
- Key Industry Developments - Mergers, Acquisitions, and Collaborations
- New Product Launches
- Impact of COVID-19 on Global Hormone Replacement Therapy Market
- Key Market Trends
- Global Hormone Replacement Therapy Market Analysis, Insights and Forecast, 2017-2028
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Therapy Type
- Estrogen and Combinations Replacement Therapy
- Thyroid Hormone Replacement Therapy Share
- Growth Hormone Replacement Therapy
- Testosterone Hormone Replacement Therapy Size
- Market Analysis, Insights and Forecast – By Indication
- Menopause
- Hypothyroidism
- Male hypogonadism
- Growth hormone deficiency
- Market Analysis, Insights and Forecast – By Route of Administration
- Oral
- Transdermal
- Parenteral
- Market Analysis, Insights and Forecast – By Distribution Channel
- Hospitals Pharmacies
- Retail Pharmacies & Stores
- Online Pharmacies
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
ToC Continue…!
Have Any Query? Ask Our Experts
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/hormone-replacement-therapy-hrt-market-102543
About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Address:
Fortune Business Insights Pvt. Ltd.9th Floor, Icon Tower, Baner –
Mahalunge Road, Baner, Pune-411045,
Maharashtra, India.
Phone:
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
